Check-Cap Ltd.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2023-11-27 | -0.17 | -0.43 | -154.24% |
| 2023-08-04 | -0.53 | -0.94 | -77.89% |
| 2023-05-11 | -0.74 | -0.76 | -2.70% |
| 2023-03-31 | -0.98 | -0.63 | +35.20% |
| 2022-11-30 | -1.00 | -0.80 | +20.00% |
| 2022-08-31 | -1.00 | -0.80 | +20.00% |
| 2022-06-01 | -1.00 | -1.20 | -20.00% |
| 2022-04-06 | -0.80 | -1.20 | -50.00% |
| 2021-11-03 | -1.00 | -0.80 | +20.00% |
| 2021-08-05 | -1.00 | -1.20 | -20.00% |
| 2021-05-12 | -1.20 | -1.00 | +16.67% |
| 2021-03-18 | -1.40 | -1.20 | +14.29% |
| 2020-11-18 | -1.60 | -1.80 | -12.50% |
| 2020-08-06 | -3.20 | -2.40 | +25.00% |
| 2020-05-27 | -6.60 | -6.80 | -3.03% |
| 2020-03-06 | -8.90 | -9.20 | -3.37% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| MBAI | +10.34% | -5.88% | -1.23% | +95.84% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +7.38% | -1.24% | +2.21% | +83.15% |